These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Epithelial hyperplasia and decreased colloid content of the thyroid gland in triiodothyronine-predominant Graves' disease. Takamatsu J; Takeda K; Katayama S; Sakane S; Morita S; Kuma K; Ohsawa N J Clin Endocrinol Metab; 1992 Oct; 75(4):1145-50. PubMed ID: 1400885 [TBL] [Abstract][Full Text] [Related]
8. Epidermal growth factor receptors in plasma membranes of normal and diseased human thyroid glands. Kanamori A; Abe Y; Yajima Y; Manabe Y; Ito K J Clin Endocrinol Metab; 1989 May; 68(5):899-903. PubMed ID: 2715291 [TBL] [Abstract][Full Text] [Related]
9. Change in serum concentration of insulin-like growth factor II (IGF-II) in patients with thyroid disease. Tada H; Watanabe Y; Futakuchi Y; Amino N Endocr J; 1994 Oct; 41(5):541-5. PubMed ID: 7889114 [TBL] [Abstract][Full Text] [Related]
10. Increased production of B-cell growth factor by T lymphocytes in Graves' thyroid: possible role of CD4+ CD29+ cells. Goto Y; Itoh M; Ohta Y; Ogawa N; Goto Y; Ohashi H Thyroid; 1997 Aug; 7(4):567-73. PubMed ID: 9292944 [TBL] [Abstract][Full Text] [Related]
11. Free and total insulin-like growth factor (IGF)-I, -II, and IGF binding protein-1, -2, and -3 serum levels in patients with active thyroid eye disease. Krassas GE; Pontikides N; Kaltsas T; Dumas A; Frystyk J; Chen JW; Flyvbjerg A J Clin Endocrinol Metab; 2003 Jan; 88(1):132-5. PubMed ID: 12519841 [TBL] [Abstract][Full Text] [Related]
12. Genes that characterize T3-predominant Graves' thyroid tissues. Matsumoto C; Ito M; Yamada H; Yamakawa N; Yoshida H; Date A; Watanabe M; Hidaka Y; Iwatani Y; Miyauchi A; Takano T Eur J Endocrinol; 2013 Feb; 168(2):137-44. PubMed ID: 23109646 [TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor-binding protein-3 (IGFBP-3) but not insulin-like growth factor-I (IGF-I) remains elevated in euthyroid TSH-suppressed Graves' disease. Wan Nazaimoon WM; Khalid BA Horm Metab Res; 1998 Apr; 30(4):213-6. PubMed ID: 9623636 [TBL] [Abstract][Full Text] [Related]
14. Detection and measurement of fat cell-binding immunoglobulins: a new method applicable to the diagnosis and study of Graves' disease. Shinozawa T; Villadolid MC; Ingbar SH J Clin Endocrinol Metab; 1986 Jan; 62(1):1-9. PubMed ID: 2999173 [TBL] [Abstract][Full Text] [Related]
15. Characterization of insulin-like growth factor receptors in human thyroid tissue. Cissewski K; Wolf M; Moses AC Receptor; 1992; 2(3):145-53. PubMed ID: 1472949 [TBL] [Abstract][Full Text] [Related]
16. Triiodothyronine generation from thyroxine in human thyroid: enhanced conversion in Graves' thyroid tissue. Ishii H; Inada M; Tanaka K; Mashio Y; Naito K; Nishikawa M; Imura H J Clin Endocrinol Metab; 1981 Jun; 52(6):1211-7. PubMed ID: 6894450 [TBL] [Abstract][Full Text] [Related]
17. Extracts and auto-oxidized constituents of certain plants inhibit the receptor-binding and the biological activity of Graves' immunoglobulins. Auf'mkolk M; Ingbar JC; Kubota K; Amir SM; Ingbar SH Endocrinology; 1985 May; 116(5):1687-93. PubMed ID: 2985357 [TBL] [Abstract][Full Text] [Related]
19. Thyroidal triiodothyronine and thyroxine in Graves' disease: correlation with presurgical treatment, thyroid status, and iodine content. Larsen PR J Clin Endocrinol Metab; 1975 Dec; 41(06):1098-104. PubMed ID: 54364 [TBL] [Abstract][Full Text] [Related]
20. [The relationship between serum thyroid autoantibodies, iodine intake, development and prognosis of Graves' disease]. Chen W; Man N; Li YS; Shan ZY; Teng WP Zhonghua Nei Ke Za Zhi; 2006 Feb; 45(2):95-9. PubMed ID: 16624113 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]